Search

everythinglearnresearchcommunity

for

Search:↓

The DLQI is a key tool for measuring quality of life in dermatology.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

Vitamin D receptor knockout mice have significant motor impairments but no cognitive deficits.

A girl had rickets due to a gene mutation affecting vitamin D response.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Diphencyprone therapy for hair loss can cause vitiligo.

A vitamin D receptor mutation causes rickets and affects immune responses.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

BTNL2 helps protect hair follicles from immune attacks.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.